SCHEMBL4357217

SCHEMBL4357217

O=C(C=Cc1c[nH]c2ncccc12)NCCN1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.49
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.45
PARP1 P09874 1/20 0.44
HDAC1 Q13547 2/20 0.43
HDAC6 Q9UBN7 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CCR2 P41597 1/20 0.41
MTNR1A P48039 1/20 0.41
DRD2 P14416 1/20 0.41
HTR1D P28221 1/20 0.41
HTR1B P28222 1/20 0.41
DRD3 P35462 1/20 0.41
SLC40A1 Q9NP59 1/20 0.40
RET P07949 1/20 0.40
ACHE P22303 1/20 0.40
WNT1 P04628 1/20 0.40
DYRK1A Q13627 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4357208 1.00 GSK3B (0.49) GSK3BCYP3A4CYP2C19KMT2APARP1
SCHEMBL4343023 0.91 GSK3B (0.61) GSK3BCYP3A4CYP2C19SMN1; SMN2ACHE
SCHEMBL4343018 0.91 GSK3B (0.61) GSK3BCYP3A4CYP2C19SMN1; SMN2ACHE
SCHEMBL4348286 0.86 SMN1; SMN2 (0.47) GSK3BSMN1; SMN2CCR2DRD2HTR1D
SCHEMBL4348279 0.86 SMN1; SMN2 (0.47) GSK3BSMN1; SMN2CCR2DRD2HTR1D
SCHEMBL4349262 0.81 ALDH1A1 (0.52) KMT2ASMN1; SMN2
SCHEMBL4349270 0.81 ALDH1A1 (0.52) KMT2ASMN1; SMN2
SCHEMBL4355475 0.81 ROCK2 (0.47) GSK3BKMT2ADYRK1A
SCHEMBL4355471 0.81 ROCK2 (0.47) GSK3BKMT2ADYRK1A
SCHEMBL4350722 0.79 AURKA (0.46) GSK3BKMT2AHDAC1HDAC6MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 EP claimed
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 EP disclosed